Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
Sarepta Therapeutics, Inc. - Common Stock   (ticker: SRPT)
Quote:() Quotes on: Yahoo | Google
5 day's Perf: 100%
1 Month Perf: 100%
3 Month Perf: 100%
YTD Perf: 100%
1 Year Perf: 100%
Stock chart
Useful Quick Links for SRPT
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :       Strong Sell       (Click Here For Details)
INSIDERS' Score: 10
0 100 10
Latest 1 month: 0 0
Latest 6 Months: 0 275,000
52 Weeks: 35,752 285,000
Gurus' Indicator :       Strong Sell       (Click Here For Details)
GURUS' Score: 5
0 100 5
Current Holdings: 168,958
Previous Holdings: 526,519
Change: 67.91%
Institutions' Indicator :          Hold          (Click Here For Details)
0 100 50
Current Holdings: 70,000,515
Previous Holdings: 68,268,528
Change: 2.54%
News And Links For The Group (Contribute a link)
[SRPT]   Healthcare Faces A Contagion  (Seeking Alpha)   27-Feb-20 09:36
[SRPT]   Biotechs Feel The Bern  (Seeking Alpha)   3-Feb-20 09:30
[SRPT]   Sarepta Therapeutics, Inc. And Arrowhead Pharmaceuticals Now Top-Ranked Biotech Stock Buys  (Seeking Alpha)   31-Jan-20 19:50
[SRPT]   The Cutting Edge Of Systematic Investing  (Seeking Alpha)   21-Jan-20 12:48
[SRPT]   Casimersen Is A Lead Catalyst For Sarepta Therapeutics As A Top 2020 Stock Pick  (Seeking Alpha)   15-Jan-20 15:26
[SRPT]   Biotech Bonanza: 2020 Outlook In An Election Year  (Seeking Alpha)   8-Jan-20 16:15
[SRPT]   Week In Review: Geneseeq And Elpiscience Close $100 Million VC Rounds; Zai Lab's PARP Inhibitor Approved For China Use  (Seeking Alpha)   30-Dec-19 22:10
[SRPT]   Roche Finishes Year With BigĀ  Deals, Gene Therapy In Focus As Competition Heats Up  (Seeking Alpha)   30-Dec-19 09:55
[SRPT]   Sarepta: Roche Partnership After The FDA's Turnaround Forms The Basis For A $158.59 Near-Term Price Target  (Seeking Alpha)   25-Dec-19 21:19
[SRPT]   Sarepta Therapeutics: Continued Progress In Duchenne MD  (Seeking Alpha)   25-Dec-19 04:37
[SRPT]   Sarepta Therapeutics: FDA Approval Reinstalls Confidence In The Pipeline  (Seeking Alpha)   17-Dec-19 12:05
[SRPT]   Once Shunned For Marketing Approval, Golodirsen Is Now A Major Win For Sarepta  (Seeking Alpha)   14-Dec-19 16:53
[SRPT]   Wave Life Sciences' Suvodirsen May Be Much Better Than Sarepta's Commercialized Eteplirsen, But May Fall Short Of Sarepta's Newer Generation SRP-5051  (Seeking Alpha)   13-Dec-19 13:24
[SRPT]   Sarepta Therapeutics Will Have A Hard Time Getting Any New DMD Drugs Past FDA  (Seeking Alpha)   18-Nov-19 08:20
[SRPT]   The Top Large-Cap Stocks To Buy Now  (Seeking Alpha)   1-Nov-19 17:30
[SRPT]   Crispr Therapeutics: At The Top Of My Shopping List  (Seeking Alpha)   21-Oct-19 11:53
[SRPT]   A Look At Merck's Keytruda And Other Headlines: The Good, Bad, And Ugly Of Biopharma  (Seeking Alpha)   8-Oct-19 11:50
[SRPT]   Sarepta Therapeutics Is Bottoming Out  (Seeking Alpha)   25-Sep-19 08:44
[SRPT]   Go-Private Offer For China Biologic Products: It Is Undervalued  (Seeking Alpha)   20-Sep-19 16:04
[SRPT]   Sarepta: Risks Are Priced In, Valuation Is Compelling  (Seeking Alpha)   16-Sep-19 15:15
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*